Xalkori 250 mg

XALKORI 250 MG capsules contain crizotinib, a targeted therapy used in cancer treatment. This oral medication is designed to inhibit specific proteins involved in cancer cell growth.

XALKORI 250 MG capsules are primarily used in the treatment of certain types of cancer. The active ingredient, crizotinib, targets proteins that play a role in cancer cell proliferation. This medication is often prescribed for patients with specific genetic markers associated with their cancer. What is XALKORI used for? It is commonly used in the management of non-small cell lung cancer and other malignancies where the targeted proteins are overexpressed.

Common effects of XALKORI 250 MG capsules may include nausea, vomiting, and diarrhea. Some patients may experience fatigue, vision changes, or swelling. These effects can vary in severity and duration. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

XALKORI 250 MG capsules should be handled with care. Store the medication at room temperature, away from moisture and heat. Keep the capsules out of reach of children and pets. Always follow the prescribed dosage and administration instructions provided by your healthcare provider.

XALKORI 250 MG capsules may interact with certain medications, including those that are metabolized by the liver. Alcohol and other substances that affect liver enzymes can also impact the effectiveness of crizotinib. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.